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STEM CELL RESEARCH: 
LICIT OR COMPLICIT? 
In Non:mber 1998 rcsc.ucher a t John s Hopkins Uni,·crsiry, Baltimore , and the University of Wisconsin- Madison announced a biological coup: They had isolated human stem cells from embryonic and fetal issue and cuhi-
,·ated them in the laboratory for as lo ng as nine 
months.' 
Excitement in the biological resear.:11 communi-
ty was palpable. Stem cells, biologists believe, 
promise significant medical benefits because of 
their abiliry to de' el up into any kind of human tis-
sue or organ-bone, muscle, blood, or brain tissue. 
Medical researchers e1wision using stem cells ro 
rep lace damaged o rgans and co restore t issue 
destroyed by Parkinson's disease, diabete , or e,·en 
Alzheimer's disease. The news media \\'JS soon 
caught up in the e:-citement, describing stem cells 
a "the biological motherlode" and "the humans' 
repair kit."' 
The euphoria quickly faded, hO\\'C\er, in tht.: 
face of a sobering fact: Since 1994, Congress has 
explicitly prohibited the use of feder,11 fund for 
research im oh·ing human embryos ( exrc:nding a 
ckcades-long de facto ban).' Could fund5 from the 
National Institutes of H ealth (NIH ) be used ro 
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support stem cell research? If nor, this new Holy 
Grail seemed certain to remain out of reach. Many 
biologists looked to Harold Varmus, director of 
the NIH, for the answer. 
In January, \'armus announced that the N IH 
would, despi te the ban on federal funding of 
embryo research, fund research on rem cells- or, 
more specifically, on "cell lines" derived from 
embryonic stem cells} For those familiar wirh the 
politics of NIH policy-making, Varmus's 
Summary In November 1998 biologists 
announced that they had discovered a way to iso-
late and preserve human stem cells. Since stem 
cells are capable of developing into any kind of 
human tissue or organ, this was a great scientific 
cou p. Researchers envision using the cells to 
replace damaged organs and to restore tissue 
destroyed by, for example, Parkinson's disease, 
diabetes, or even Alzheimer's. 
But, since stem cells are taken from aborted 
embryonic and fetal tissue or "leftover" in vitro 
embryos, their use raises large ethical issues. The 
National Institutes of Health (NIH) recently decided 
to fund research employing, not stem cells, but 
"cell lines· derived from them. The NIH has essen-
tially made an ethical determination, finding suffi-
cient "distance" between cell lines and abortion. 
Can Catholic universities sponsoring biological 
research agree with this finding? 
Probably not. In Catholic teaching, the concept 
of "complicity" would likely preclude such 
research. However, Catholic teaching would proba-
bly allow research done with stem cells obtained 
from postpartum placental tissue and from adult 
bone marrow and tissue. These cells, which lack 
the pluripotency of embryonic and fetal stem cells, 
are nevertheless scientifically promising and do 
not involve the destruction of human life. 
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announcement was not in irself surprising. \Vhar 
\\"a5 inrcresting was his argumcnr. There is a differ-
ence, he said , bcrween cond ucring research on 
embryos rhcmselves and conducting research on 
cells derived from embryo\. Therefore, although 
researchers could not use tederal money to isolare 
and cultivate stem cells from embryonic or fetal tis-
sue, they could use it to conduct stem cell research 
if private funds had been used to derive the cells in 
the first place. 
In making this argument, Varmus offered an 
intrigui ng secular variant of o ne of the most 
complex issues in Catholic morality, the issue of 
complicity. T he N IH has essentially determined 
there is sufficient legal "distance" between rhe 
source o f the stem cell lines and the cell lines 
themseh·cs. Working \\irh cell lines of cmbryoni -
ca lly derived tissue does nor, in the N IH 's view, 
involve one in human embryo research funded 
by federal money. 
But is there sufficient moral distance? Since stem 
cells arc derived from aborted embryos and !Crus-
es, o r from " leftover" in vitro embryos, \\ill those 
who conduct such research (or those who might 
benefit medjcally from them) be complicit in an acr 
of abortion- in, that is, the destrncrion of human 
li fe? This re m ain an impo rtan t quest ion for 
Catholic Luliversities sponsoring bio logical research 
and for Catholic researchers. 
The recent N IH decision makes the question 
even more pressing. The funding issue changes t he 
land scape dramat icall y. The s t e m cell work 
announced in November 1998 relied exclusively 
on funding from pri,·ate biotech firms. No'' rhar 
the federal fl oodgates are opening, stem ce ll 
research projecrs will multiply exponentially. As 
the fruits of this resea rch are translated inro the 
therapeutic armamentarium, Carbolic healthcare 
i.nstirutions and their patiems ,,;ll find themselves 
dealing wit h therapy rhat lies under a shadow. 
Those \\"ho take their Carbolic ide ntity seriously 
will have to grapple with the question: What /epef 
of im•ol11ement with stem cell research and the 
products therefrom constiwtes complicity? 
TROUBLE AT THE SOURCE 
H ow is stem cell research related to the destruc-
tio n of human life? The answer to this question 
varies. In some instances, rhe connection between 
the cells and such destructio n is unmistakable, in 
others it is clearly absenr , and in st ill ochers it 
remains dispured. 
The connection is obvious in the \\"Ork pub-
lis h ed in Novembe r by the Jo hn s H opkin s 
University research team. John Gearhart and his 
coll eagues o btained five- to-nine -week-o ld 
embryos and fetuses immediately following abo r-
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rions and deri,·ed stem cells from them. The har-
vesting of these stem cells depended on abortion. 
H owever, this need nor always be rhe case. 
Findings from urher stuilics suggest thar stem cells 
can be also obtained from postpaitum placental 
ti ssue and from adult bone marrow, brain, and 
orher organs.; Altho ugh such cells do not possess 
rhe same plLLripotency as embryonic and tctal srem 
cells, they can, research indicares, produce a variety 
of blood cells, bone, cartilage, fat, tendon, muscle, 
and myclin-cells that promi~e treatment for d isor-
ders ranging from leukemia ro mul tiple sclerosis, 
from Alzheimer's to Parkinson's. And they do not 
involve aborted fetuses. 
There is a third merhod for obraining srcm cells. 
The connection bet\\'een it and abortion is d isput-
ed, even among Carholic moral theologians. This 
method , cm ployed by James Thompson and a 
team of researchers at the University ofWisconsin-
.\1adison, deri,·es rhe stem cells from unimplanted 
embryos created rhrough in vitro fertilization. 
Thompson and his colleagues obtained from a fer-
tility clinic fertilized eggs " left O\·er" from in \itro 
fertilization. Q,·er Se\·en days or so, the researchers 
allowed these fertilized zygmes to develop into 
blasrocysrs, which t hey rhcn dissected for their 
stem cells. 
Does t his use o f an embryo-\\'hich is de-
stroyed in the process of harvesring the stem 
cells-consrirute an abortion? From the pcrspec-
ti,·e of the magisterium, t he answer is yes. The 
Carholic Church explicitly forbids nor onl}' ilirecr 
involvemcnr in an abortion as a form of complic-
ity; it also forbids the de rruction of, experimcn-
r.ttion on, o r orhc r degrJdarion of a human 
embryo ,n any stage after fertil ization." For those 
who believe rhat human li fe begins at conceptio n, 
any destruction or degrad,nion of embryos is 
morally equivalenr ro abrntion. 
Some Carbolic commenrarors d isagree, howev-
er. Those, for example, who hope rhe Church will 
e\•entually allo\\' both in \~tro fertilizatio n and srem 
cell research have tried to craft an argument that 
reconfig ures the moral starus of unimplanred 
embryos. · The argwnent require a distinction to 
be made between human life and human individu-
ality. These commcnrators suggest that conception 
is a process, rather than a single moment, and one 
rhar is not complere until approximately 14 days 
after fertilization. During this time, the fertil ized 
egg can srill split in two (can " twin," in other 
words); in thCOI)', each cell of the blasrocysr could 
give rise ro a separare individual. Not until the 
14th d ay, w he n rhe blasrocyst h as normally 
implanted itself in the uterine wall and cell iliftcr-
entiarion has begun , would rhere be an actu al 
human indi,idual. Only after this, according to rhe 
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argument, would destruction of the embryo be 
cqui,·alent to abortion. 
STEM Cm LINES 
A t issue's source must therefore be taken into 
account whenever one is considering the issue of 
complic ity in stem cell research. But recent 
dc\'elopmcnts present another, even more per-
plexing twist. 
Cell lines are embryonic and fetal stem cells that 
researchers have kept alive and allowed to repro-
duce into new cells of the same type. Now that 
certain technical problems in this difficult process 
arc gradually being resolved, researchers can pre-
serve cell lines for as long as nine 111ontl1s. Stern 
cells reproduced in this way may retain tl1eir radical 
ability to develop into any type of human tissue. 
If the scientists who n:produced the original 
cell lines decide to share them with o th er 
researchers-as they surely will-will this sharing 
establish a sufficient moral " distance" between the 
original act of abortion ( or destruction uf 
embryos) and the secondary or tertiary research-
ers? Could a Catholic researcher engage in such 
research without qualms of conscience? Such a 
researcher might argue that developing cell lines is 
a way of bringing good out of evil, a praiseworthy 
act. One might, fo r example, donate to science 
tlie organs of a murdered family member without 
condemning the murder any less strongly. Can 
researchers, by focusing on the cell Linc , dissociate 
rhemsel\'es from the original abortion? And can 
ordinary people accept thc products of such 
research (e.g., the medicines and replacement tis-
sues and organs) witliout being implic.:ated in the 
act that made the products possiblc? Or wil l 
everyo ne involved-patients as well as 
researchers-be complicit in t he destruction of a 
hLUnan embryo? 
THE QUESTION OF COMPLICITY 
To answer tl1ese questions, we must turn to the 
notion of complicity. In Catliolic teaching, "com-
plicity" in an other person's crime is a broad con-
cept, related to but not synonymous with the con-
cept of cooperation . Ethicists sometimes distin-
guish between formal complicity (before tl1e act ) 
and material complicity (after the fact ), depending 
on tlie accomplice's activity, approval, or inten-
tions, and on the riming involved. 
James Burtchaell has provided tlie most exten-
sive recent treatment of complicity in his analysis of 
the analogous issue of the use of fetal tissue for 
research and transplantation .8 Burtchaell posits 
four types of moral complicity, the first two of 
which seem most relevant to stem cell research: 
iActive collaboration in the deed itself 
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BurtchaeU's first type is roughly cqui,·alcnr ro 
tlic concept offonnal cooperation. In Eva11gelium 
11itae, Pope John Paul rI says such cooperation is 
tl1e same as participating in an edl act or at least 
sharing rhc e\·ildocr's intention: "Christians, like 
all people of good will, arc called upon under brrave 
obligation to conscience nor to cooperate fom1ally 
in practices which even if pem1ittcd by ci\'il legisla-
tion are conunry to God's law. Indeed, from tl1e 
moral standpoi.nt, it is never licit to cooperate for-
mally in e\~I. Such cooperation .. . can be defined 
as a direct participation in an act against innocent 
life or sharing in the immoral intention of the per-
son committing it. " 10 
Such complicity of intention would apply not 
only to the actual perpetrators but also to those 
who by their actions seem to suppo rt tlie act, for 
example, those who donate fetuses or fertilized 
embryos for research purposes. 
However, direct involvement is not required to 
raise questions of complic.:iry. There may be, as 
BtLrtchacll note , an indirect association with the 
immoral act that implies approval. Does o ne 
become formally or materially complicit after tl1e 
fact th rough simple disregard and silence-espe-
cially if one knows about the evil act and is benefit-
ing from it? When I benefit o,·er and O\'er again 
from a crime while simply ignoring the crime itself, 
do I place myself in an established relationship 
with that crime whetlicr I approve of' it or not? As 
Burtchacll t arcs, "A partnership whereby one 
achieves direct benefit from another person's inju-
rious behavior, afi:er tl1e fact, can place the former 
in silent but unmistakable alliance ,,.itJi what the 
latter is doing. " 11 
DEGREES OF DISTANCE 
Bur arc there any limits on this notion of material 
c.:omplicity after the fact? How close is too dose? 
How much distance is required? Although there 
are no d ear-cut answers, the notion of material 
cooperation might be of assistance here. In tl1e 
Catholic moral tradition, an action that is con-
joined to but d oes nor inte nd a p articular 
immoral act may be justifiable if it is sufficiently 
re111ote. H ow mig ht o ne achieve sufficient dis-
tance from the actual evil or symbolic power of an 
inunoral action? There are six possible ways this 
can be done. 
Time If the two actions arc separated by a signifi-
c.:am amount of time, the later one may be justifi-
able. H owever, time docs nor heal all ills. As 
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Bunchaell observes, most American re5earchers 
refused to use the research data of Nazi doctors 
"ho experimemed on death-camp pri oners e,·en 
though decades had passed since those terrible 
crimes occurred. 
Steps of Separation A second possibility involves the 
degree of separation- that is, the number of steps 
intervening between a present act and a prior one. 
An analogy is the modern prac tice of bu~ing 
inexpensive goods produced in Asian "sweat-
shops." A wholesale c lothing merchant who 
obtains goods from manufacturers known to treat 
their worker in a brutal manner is certainlr an 
accomplice, after the fact, in the brutalitr. ls a 
retailer who eventually receives the goods, perhaps 
several steps down the line, also an accomplice? 
Are you and I, who arc wearing the clothes, 
accomplices? Although degree of separation is an 
important con ideration, ethicists reflecting on 
modern social e,·ils h~n e frequent!)' pointed out 
that the silence and putative neutrality of good 
people often allow evil to flourish . 
Ongoing Practice \\'hether the original evil act is con-
tinuing makes a difference. Although many scien-
tists adamantly oppose the use of the Nazi dcat11-
camp data mentioned above, others would argue 
that employing it could be justified ince the prac-
tice~ that produced the d ata ha,•e long si nce 
ceased. (By the same measure , t hough, o ne might 
return to the S\\ eatshop example and argue that as 
long .1s the practices continue, no degrees of sepa-
ration can sufficiently separate a cognizant pur-
chaser !Tom the brutality involved in producing the 
goods he or she buys. ) 
Impact on Social Fabric A fourth consideration is 
whether rdi.1sing ro participate in a ct of practices 
becau e of their link with prior e,·il would, if prac-
ticed broadly, be socially disrupti,·c and detrimen-
tal to the common good. Which goods or scn•ice~ 
ha\ e not been tainted by some e\il at some point 
along the line of production? One could argue, for 
example, that American civilization is based on the 
theft by European settlers of Indian land, that our 
economy was tor many years based on the blood 
and sweat of African slaves. If contemporary 
Americans were to rake too broad a \iew of their 
complicity in these crimes, they might cffecti,·ely 
paralyze t he nation. Such a paralysis, precluding 
the reali zation of goods important to the human 
community, would be a 5in of omission. 
Nature and Immediacy of Goods Insofar as norions of 
complicity and cooper.nion draw on the principle 
of double effect, the nature and immediacy of the 
good produced-and the absence of reJ.! alterna-
tives to such goods-must be taken into account. 
The classic example of justifiable remote C<)Opera-
tion is the janitor who works in a hospiral that per-
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forms ahonions. As long as the janitor neit11er par-
ticipates directly in the abortions nor approves of 
them, he is not considered complicit, .1ssuming 
that his livelihood and that of his family depends 
on the job because no otl1er is available. However, 
as the goods become less central to human flour-
ishing, this justification becomes more tenuous. 
Severity of Act The degree of one's material complici-
ty after the fact rests not only on the distance from 
the crime but on its se,·erity as weU. We are still so 
shocked by the horrors of Nazi death camps that 
most of us abhor the thought of benefiting in any 
way from this e\il. Are abortions or ot11er forms of 
destmction of human embryos on the same level? 
Although such considerations help us t hink 
about how to distance one act from another, none 
is detenninati,·e, nor can a formula be developed 
from them. Dista nce from a c rime canno t be 
assessed in o bjective units of measurement; it 
depends on human perception and tl1e symbolic 
power of data. Unscrupulous merchants can com-
mingle clothing from sweatshops "ith that from 
legitimate sources ro the point where it may be 
unreasonable to try to distinguish them from each 
o ther. Noting t11is fact is not an attempt to palliate 
a ensiri,·e con cience. It is to point out one way 
the clothing line loses its symbolic po\\ er to ernke 
the crime. But a notebook captured in a Nati 
death camp retains that power. 
CoMPLICITY AND STEM Cm LINES 
Having discussed various d imension s of the 
complicity issue, we return to our original ques-
tio n: What level of involvement with stem cell 
research and the products therefrom constitutes 
COlllplicity? 
Despite disagreement about the status of unim-
planted embryos, CathoLic moral teaching clearly 
holds tl1ose who dissect blastocysts from stem cells 
equal in moral culpability to those who perfonn 
abortions. ln additio n, those whose actions arc 
closely linked to the dc1ivation of stem cells through 
the destruction of human life- those "ho, for exam · 
pie, donate Ictuses o r tcrtilized embryos for research 
purposes, or procure consent from donors- would 
be considered morallr complicit in a gra\'c C\il. 
In the same way, the issue of indirect participa-
tion through association is clear. Close coopera· 
tion between a researcher and a provider of ,·olun-
tary abonions or a fcnility clinic appears to bring 
the resean:h close enough formally and materially 
to the abortion to smack of complicity. Whether 
the researcher obtains aborted fetuses in order to 
dcri,·e stem cells from them or obtains stem cells 
dc1ived from unimplanted embryos, the researcher 
has arranged a tran action that eems to encour-
age, support, or even lend legitimacy to the 
HEALTH PROGRESS 
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Ill November 1998 researchers at Johns H opkins University, Baltimore, and the Uni\·ersit:y of Wisconsin-Madison announced a biological coup: ll1ey had isolated human stem cells from emb1yonic and fetal issue and culti-
vated them in the laboratory for as long as nine 
momhs.1 
Excitement in the biological research communi-
ty was palpable. Stem cells, biologists believe, 
promise sig nificant medical benefits because of 
their ability to de\·elop into any kind of human tis-
sue or organ-bone, muscle, blood, or brain rissue. 
Medical researchers emision using stem cells to 
replace damaged o rgans and ro restore tissue 
destroyed by Parkinson's disease, diabetes, or even 
Alzheimer's disease. The news media was soo n 
caught up in the excitement, describing stem cells 
as "the biological mothcrlode" and "the humans' 
repair kit. "2 
The euphoria quickly faded, however, in the 
face of a sobering fact: Since 1994, Congress has 
explicitly prohibited the use of federal funds for 
research involving human embryos (extending a 
decades-long de facto b,m).' Could funds from the 
National Institutes of Health ( I H ) be used to 
support stem cell research? If not, this new Holy 
Grail seemed certain to remain out of reach. Many 
biologists looked to Harold Varmus, director of 
the NIH, for the answer. 
111 January, Varmus announced that the NIH 
would, despite the ban on federal funding of 
embryo research, fund research on stem cells-or, 
mo re specifically, on "cell lines" derived from 
embryonic stem cells.' For those familiar with the 
politics of ~ IH policy-making, Varmus's 
announcement was not in itself surprising. What 
was interesting was his argw11ent. There is a differ-
ence, he said , between conducting research on 
embryos themselves and conducting research on 
cells derived from embryos. Therefore, although 
researchers could not use federal money to isolate 
and cultivate stem cells from embryonic or fetal tis-
sue, they could use it to conduct stem cell research 
if private funds had been used to derive the cells in 
the first place. 
In making chis argument, Varmus offered an 
int rigu ing secular variant of one of the mosr 
complex issues in Catholic morality, the issue of 
complicity. The IH has essentially determined 
there is sufficient legal "distance" berwccn the 
source of the stem cell lines and the cell lines 
themselves. Working with cell lines of embryoni-
cally derived tis ue docs not, in the N IH 's \'iew, 
involve one in human embryo research funded 
by federal money. 
But is there sufficient moral distance? Since stem 
cells are derived from aborted embryos and fetus-
HEALTH PROGRESS 
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es, or from "leftover" in \~tro embryos, will those 
who conduct such research (or those who might 
benefit meclically from them) be complicit in an act 
of abortion- in, that is, the destruction of human 
life ? T his remains an important quest io n for 
Catholic universities sponsoring biological researcl1 
and for Catholic researchers. 
The rec em I H decision makes the question 
even more pressing. The funding issue changes the 
landscape dramatically. T he stem cell work 
announced in 'ovember 1998 relied exclusively 
on funding from private biotech firms. Now that 
the federal flood gates are opening, stem cell 
research projects \\~II multiply exponentially. As 
the fruits of this research are translated into the 
therapeutic armamentarium, Catholic healthcare 
institutions and their patients will fmd themselves 
dealing with therapy that lies under a shadow. 
Those who take their Catholic identity seriously 
will have ro grapple with the question: What level 
of i111•oil'e111mt ll'ith stem cell nsearch n11d the 
products therefrom co11stit11tes co111plicity? 
TROUBU AT THE SOURCE 
H ow is stem cell research related to the destn.JC-
tion of human life? The answer to this question 
v:uies. In some instances, rhe connection between 
the cells and such destruction is unmistakable, in 
others it is clearly absent, and in still others it 
remains disputed . 
The connect ion is obvious in the work pub-
1 ished in No\'em ber by the Jo h ns Hopki ns 
University research team. John Gearhart and his 
colleagues obtained fi\'e - to- ni ne-wee k-old 
embryos and fetuses immediately following abor-
tions and derived stem cells from them. The har-
vesting of these stem cells depended on abortion. 
However, this need not always be the case. 
Findings from other studies sugge~t that stem cells 
can be also obtained from posrparrum placental 
tissue and from adult bone marrow, brain, and 
other organs.' Although such cells do not possess 
the same pluripotency a embryonic and feral stem 
cells, they can, research indicates, produce a variety 
of blood cells, bone, cartilage, fat, tendon, muscle, 
and myelin-cells that promise trcarmem for disor-
ders ranging from leukemia to multiple sclerosis, 
from Alzheimer's to Parkinson's. And they do not 
inrnl\'e aborted fetuses. 
There is a third method for obtaining stem cells. 
The connection between it and abortion is disput -
ed, even among Catholic moral theologians. This 
method, employed by James Thompson and a 
team of researchers at the University ofWisconsin-
Madison, derives the stem cells from unirnplanted 
embryos created through in \'itro fe rtiliL.ation. 
Thompson and his colkagues obtained from a fer-
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researcher \\ill not he com1pred by the C\il. 
Technology and the "Culture of Death" Recent Catholic 
t eaching on bioethics, as well as the general 
moral reaching of John Paul IJ , point toward a 
second broader issue: the danger that, in mod-
ern society, rhe requirements of technology wi ll 
rake precedence m·er human needs. One hears, 
over and over in t he C hurch's recent imtruc-
tions on bioe1 hies, warnings against reducing 
the human being "to an objecr of scientific tech-
nology," in which the sole criteria for success 
a re " technical efficien cy" and "control and 
dominio n . "IJ One finds, combined with these 
warnings, appeals to re\·ere human dignity and 
the sanctity of human life. 
A Theological Vision Critics frequently object ro the 
way the Church, in its discussion of topics like 
homologous in \'itro fertilization, places human 
dignity and technology in o pposition to each 
o ther. Yet understanding the Church's teaching 
requires a charitable assessment of the fundamen-
tal philosophical and theological differences 
between these two phenomena . Fundamental to 
the Church's appeal is a vision of narure and natu-
ral processes as "creation"-the tangible matrix 
that extravagantly and incarnationally mediates 
God's grace and presence co the world, locating 
each of us in a broader and \'ital context of interre-
latedness and community. To lose a sense of 
nature as creation is 10 lose a sense of life in its 
wholeness, in its dignity, in its mystery. It is to 
lose a sense of the person as a whole entity expe1i-
encing the whole oflife. 
Such a loss results in an exclusive and reduction-
istic concentration on immediate control of some 
circumscribed funcrion of lite. Abstracted !Tom its 
context in creation and the human community, no 
dimension of life can fl ourish. Such idolatrous 
abstraction leads to what John Paul II calls " the 
culture of death." in1aring stem cell research and 
its legi timate drive toward life in the dual context 
of the \\ holeness of human life and the culture of 
death may we ll give this reaching a new urgency 
and intensity. 
Two ROADS TO RESEARCH 
Stem cell research proceeds. In April an IH ad,i -
SOI)' panel issued draft gui<lelines allowing federal 
financing of research wi1h human embryonic stem 
cells. u Research on altemati\·es to embryonic stem 
cells proceeds a~ well. Perhaps tl1e research involv-
ing alrernati\'eS \\i ll prO\e to be technically and 
therapeutically mo re facile char that employing 
embryos, and will thereby render questions of 
complicity moot. 
In the meantime, conscientious Catholics and 
o tl1cr people of faith have an opportunity to reflect 
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on rhe reasonable and rheological bases for this 
new <lirection in medicine in light of where our 
hearts and the Spirit lead us. a 
11Jc authors are gnrujitl to 1'1111/ Benson, f'/JD, of the pbi-
losopb.Y dcpartmwt, U11il'ersi1y of D11y1011, for dismssi11 .. rr 
this topic witb tbcm, 1111d to the 1mi1•enit_Y's Et/Jim/ 
Decifiom Com111i1tu for sl111r111g its drltbrratiom 111 to 
1'•1mher the i11stit11tio11 shortld develop 11 policy goi•cmillg 
stem cell remffch. 
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